Picture of ALR Technologies SG logo

ALRTF ALR Technologies SG Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-29.11%
3m-34.44%
6m+30.93%
1yr-65.09%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-67.73%
50d MA-44.01%
200d MA-33.41%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-39032.24%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of ALR Technologies SG EPS forecast chart

Profile Summary

ALR Technologies SG Ltd. is a data management company. It has developed a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA-compliant Diabetes Solution product that collects data from blood glucose meters (BGM) and continuous glucose monitoring device (CGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. From this technology portfolio, the Company has developed the Diabetes Solution product for human health, and the GluCurve product for animal health. The Company is focused on the enhancement of adherence to disease and healthcare management programs through artificial intelligence, machine learning, patient monitoring, and improved communications. Its primary business markets are healthcare providers, the providers of health insurance, and the providers of disease and care management services, including the home care industry.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
May 16th, 2020
Public Since
March 13th, 2000
No. of Shareholders
131
No. of Employees
6
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
635,466,844
Blurred out image of a map
Address
9 Raffles Place, #26-01 Republic Plaza, SINGAPORE, 048619
Web
https://www.alrt.com/investors
Phone
Auditors
Dale Matheson Carr-Hilton LaBonte LLP

ALRTF Share Price Performance

Upcoming Events for ALRTF

Similar to ALRTF

Picture of Aamaxan Transport logo

Aamaxan Transport

us flag iconPink Sheets on Nasdaq

Picture of ACCUSTEM SCIENCES logo

ACCUSTEM SCIENCES

us flag iconPink Sheets on Nasdaq

Picture of Acutus Medical logo

Acutus Medical

us flag iconPink Sheets on Nasdaq

Picture of ADM Tronics Unlimited logo

ADM Tronics Unlimited

us flag iconPink Sheets on Nasdaq

FAQ